EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Endoscopic ultrasound-guided tissue acquisition as a gateway to precision oncology in pancreatic cancer: current evidence and evolving clinical utility

Sung Woo Ko, Seung Bae Yoon

Clinical Endoscopy · 20.05.2026

DOI: 10.5946/ce.2025.431 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Endoscopy, online erschienen am 20.05.2026. Verfasst von Sung Woo Ko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehensive genomic profiling (CGP) is an important component of precision oncology in pancreatic ductal adenocarcinoma (PDAC), a malignancy with limited therapeutic options and poor overall survival. Endoscopic ultrasound (EUS)-guided tissue acquisition is the primary means of obtaining specimens for next-generation sequencing (NGS), offering high diagnostic accuracy and a favorable safety profile. Recent studies and meta-analytic data have shown that the success rate of NGS using EUS-derived samples is approximately 84%, although sequencing performance is influenced by needle characteristics, specimen type, preprocessing methods, and platform-specific DNA requirements. While the superiority of either fine-needle aspiration or fine-needle biopsy has not been definitively established, 22-gauge or larger needles may enhance tissue adequacy when technically feasible. Major genomic alterations, such as KRAS, TP53, CDKN2A, and SMAD4, have been consistently identified using EUS-derived specimens, with more than 80% concordance compared to surgical tissue. Actionable mutations, including homologous recombination repair gene defects, were found in approximately 18% of patients, supporting the clinical value of CGP in guiding therapy. Emerging biomarkers, including KRAS subtype, tumor mutational burden, microsatellite instability, and variant allele frequency, may further refine individualized treatment strategies. Continued optimization of EUS-based sampling and processing will facilitate CGP integration into PDAC management.

Schlagwörter

Stichwörter der Autor:innen

EndosonographyFine needle aspirationGenesPancreatic neoplasmsSequence analysis

Autor:innen und Institutionen

  • Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Zitieren

APA

Ko, S. W., & Yoon, S. B. (2026). Endoscopic ultrasound-guided tissue acquisition as a gateway to precision oncology in pancreatic cancer: current evidence and evolving clinical utility. Clinical Endoscopy. https://doi.org/10.5946/ce.2025.431

Vancouver

Ko SW, Yoon SB. Endoscopic ultrasound-guided tissue acquisition as a gateway to precision oncology in pancreatic cancer: current evidence and evolving clinical utility. Clinical Endoscopy. 2026. doi:10.5946/ce.2025.431

BibTeX
@article{Ko2026,
  author = {Ko, Sung Woo and Yoon, Seung Bae},
  title = {Endoscopic ultrasound-guided tissue acquisition as a gateway to precision oncology in pancreatic cancer: current evidence and evolving clinical utility},
  journal = {Clinical Endoscopy},
  year = {2026},
  doi = {10.5946/ce.2025.431}
}
Kostenlos starten →